← Back to Search

Dietary Supplement

Vitamin D3 + Omega-3 Fatty Acids for Infections

N/A
Waitlist Available
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights

Study Summary

This trial is investigating whether taking daily dietary supplements of vitamin D3 or omega-3 fatty acids reduces the risk of developing cancer, heart disease, and stroke.

Eligible Conditions
  • Infections
  • Human Cathelicidin Antimicrobial Peptide

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
hCAP-18
upper respiratory infection
Secondary outcome measures
antimicrobial-treated infection
cellulitis
infection-related hospitalizations
+2 more

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: vitamin D placebo + fish oilActive Control2 Interventions
vitamin D placebo + Omacor
Group II: vitamin D + fish oilActive Control2 Interventions
vitamin D3 + Omacor
Group III: vitamin D + fish oil placeboActive Control2 Interventions
vitamin D3 + fish oil placebo
Group IV: vitamin D placebo + fish oil placeboPlacebo Group2 Interventions
vitamin D placebo + fish oil placebo

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,611 Previous Clinical Trials
11,444,645 Total Patients Enrolled
24 Trials studying Infections
24,542 Patients Enrolled for Infections

Media Library

Fish Oil (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT01758081 — N/A
Infections Research Study Groups: vitamin D placebo + fish oil, vitamin D + fish oil, vitamin D + fish oil placebo, vitamin D placebo + fish oil placebo
Infections Clinical Trial 2023: Fish Oil Highlights & Side Effects. Trial Name: NCT01758081 — N/A
Fish Oil (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01758081 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1754 spots leftby Apr 2025